Postpartum Depression Research

TMS and Postpartum Depression 

We are looking for women who are interested in treating their postpartum depression with a non-medication treatment called Repetitive Transcranial Magnetic Stimulation (TMS). TMS is an effective, safe, non-invasive alternative treatment to medications for people with Major Depression. TMS is an FDA approved treatment for people suffering with depression, and the American Psychiatric Association has recently recommended TMS as a treatment modality for depression. TMS has not yet been studied extensively in women with postpartum depression, although one small study documented a benefit. 

To participate in this research study, you must be between the ages of 18-45, have given birth to a single, healthy child within the past 12 months, be diagnosed with depression, and not be taking an antidepressant medication. The research study involves an intake assessment and treatment phase (daily TMS treatment visits for 4 weeks). All office visits, medical evaluations, and rTMS treatments related to this study will be provided at no cost to patients. Childcare may be provided. Participants will receive $250 compensation upon completion of all study visits.

PPD ACT Welcome screen

For more information contact Brenda at (919) 843-8084 (


PPD ACT Research App

PPD ACT is a research app for women who have ever experienced postpartum depression (PPD) or psychosis (PPP.) The goal of the study is to improve detection, treatment and prevention of PPD and PPP by finding the genetic basis of these disorders. Women who participate will download the PPD ACT app, fill out questionnaires and if eligible, submit a saliva sample.

You may be eligible to join if you:

• Are female aged 18 or above
• Have had a live birth
• Have an iOS or Android device

For more information, find us on the web at, Twitter @pactforthecure, Facebook @PPDACT, email or find the app in the iTunes or Google Play store by searching “PPD ACT”.